These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6429730)

  • 41. What do we gain from the sixth stool guaiac?
    Neuhauser D; Lewicki AM
    N Engl J Med; 1975 Jul; 293(5):226-8. PubMed ID: 1143302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening tests for occult blood.
    Trotman IF
    Lancet; 1980 May; 1(8176):1036. PubMed ID: 6103374
    [No Abstract]   [Full Text] [Related]  

  • 43. [Validity of the guaiac test (Hemoccult) in the diagnosis of neoplasms of the left colon in symptomatic patients].
    Saccomanno S; Castiglione G; Aste H; Pacini F
    Minerva Dietol Gastroenterol; 1985; 31(4):635-9. PubMed ID: 4088513
    [No Abstract]   [Full Text] [Related]  

  • 44. Attitudes toward colorectal cancer screening tests.
    Ling BS; Moskowitz MA; Wachs D; Pearson B; Schroy PC
    J Gen Intern Med; 2001 Dec; 16(12):822-30. PubMed ID: 11903761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colon cancer screening: which non-invasive filter tests?
    Pox C
    Dig Dis; 2011; 29 Suppl 1():56-9. PubMed ID: 22104755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Early diagnosis of colorectal cancer in the aged (author's transl)].
    Weiss W
    Aktuelle Gerontol; 1980 Feb; 10(2):79-87. PubMed ID: 6106409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Screening for colorectal cancer with a test for occult blood in stool (author's transl)].
    Uhlig K; Jacobasch KH; Lampe J; Wiedemann FH; Schönberner H
    Arch Geschwulstforsch; 1981; 51(8):717-20. PubMed ID: 7340717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.
    Haggerty J; Tudiver F; Brown JB; Herbert C; Ciampi A; Guibert R
    Can Fam Physician; 2005 Dec; 51(12):1658-9. PubMed ID: 16926946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal cancer detection in a Community Hospital Screening Program.
    Kurnick JE; Walley LB; Jacob HH; Nakayama L
    JAMA; 1980 May 23-30; 243(20):2056-7. PubMed ID: 7373745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.
    Chausserie S; Levillain R; Puvinel J; Ferrand O; Ruiz A; Raginel T; Lantieri O; Launoy G; Guittet L
    Int J Cancer; 2015 Apr; 136(8):1827-34. PubMed ID: 25195670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Family physicians' beliefs about breast cancer screening by mammography.
    Cummings KM; Funch DP; Mettlin C; Jennings E
    J Fam Pract; 1983 Dec; 17(6):1029-34. PubMed ID: 6644252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experience with haemoccult screening in Hungary. A multicenter trial.
    Siba S
    Hepatogastroenterology; 1983 Feb; 30(1):27-9. PubMed ID: 6601046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The guaiac test in the diagnosis of colorectal neoplasms].
    Adamsen S
    Nord Med; 1983; 98(4):107-9. PubMed ID: 6603610
    [No Abstract]   [Full Text] [Related]  

  • 55. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colorectal cancer screening with double-contrast barium enema: a national survey of diagnostic radiologists.
    Klabunde CN; Jones E; Brown ML; Davis WW
    AJR Am J Roentgenol; 2002 Dec; 179(6):1419-27. PubMed ID: 12438029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
    Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
    Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity of hemoccult testing in patients with colorectal carcinoma.
    Wexner SD; Brabbee GW; Wichern WA
    Dis Colon Rectum; 1984 Dec; 27(12):775-6. PubMed ID: 6499615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.